1 Introduction to Research & Analysis Reports
1.1 Hematology Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hematology Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hematology Drugs Overall Market Size
2.1 Global Hematology Drugs Market Size: 2022 VS 2029
2.2 Global Hematology Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Hematology Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Hematology Drugs Players in Global Market
3.2 Top Global Hematology Drugs Companies Ranked by Revenue
3.3 Global Hematology Drugs Revenue by Companies
3.4 Global Hematology Drugs Sales by Companies
3.5 Global Hematology Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Hematology Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Hematology Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Hematology Drugs Players in Global Market
3.8.1 List of Global Tier 1 Hematology Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Hematology Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Hematology Drugs Market Size Markets, 2022 & 2029
4.1.2 OTC
4.1.3 Rx Drugs
4.2 By Type – Global Hematology Drugs Revenue & Forecasts
4.2.1 By Type – Global Hematology Drugs Revenue, 2018-2023
4.2.2 By Type – Global Hematology Drugs Revenue, 2024-2029
4.2.3 By Type – Global Hematology Drugs Revenue Market Share, 2018-2029
4.3 By Type – Global Hematology Drugs Sales & Forecasts
4.3.1 By Type – Global Hematology Drugs Sales, 2018-2023
4.3.2 By Type – Global Hematology Drugs Sales, 2024-2029
4.3.3 By Type – Global Hematology Drugs Sales Market Share, 2018-2029
4.4 By Type – Global Hematology Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Hematology Drugs Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Drugs Store
5.1.4 Other
5.2 By Application – Global Hematology Drugs Revenue & Forecasts
5.2.1 By Application – Global Hematology Drugs Revenue, 2018-2023
5.2.2 By Application – Global Hematology Drugs Revenue, 2024-2029
5.2.3 By Application – Global Hematology Drugs Revenue Market Share, 2018-2029
5.3 By Application – Global Hematology Drugs Sales & Forecasts
5.3.1 By Application – Global Hematology Drugs Sales, 2018-2023
5.3.2 By Application – Global Hematology Drugs Sales, 2024-2029
5.3.3 By Application – Global Hematology Drugs Sales Market Share, 2018-2029
5.4 By Application – Global Hematology Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Hematology Drugs Market Size, 2022 & 2029
6.2 By Region – Global Hematology Drugs Revenue & Forecasts
6.2.1 By Region – Global Hematology Drugs Revenue, 2018-2023
6.2.2 By Region – Global Hematology Drugs Revenue, 2024-2029
6.2.3 By Region – Global Hematology Drugs Revenue Market Share, 2018-2029
6.3 By Region – Global Hematology Drugs Sales & Forecasts
6.3.1 By Region – Global Hematology Drugs Sales, 2018-2023
6.3.2 By Region – Global Hematology Drugs Sales, 2024-2029
6.3.3 By Region – Global Hematology Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Hematology Drugs Revenue, 2018-2029
6.4.2 By Country – North America Hematology Drugs Sales, 2018-2029
6.4.3 US Hematology Drugs Market Size, 2018-2029
6.4.4 Canada Hematology Drugs Market Size, 2018-2029
6.4.5 Mexico Hematology Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Hematology Drugs Revenue, 2018-2029
6.5.2 By Country – Europe Hematology Drugs Sales, 2018-2029
6.5.3 Germany Hematology Drugs Market Size, 2018-2029
6.5.4 France Hematology Drugs Market Size, 2018-2029
6.5.5 U.K. Hematology Drugs Market Size, 2018-2029
6.5.6 Italy Hematology Drugs Market Size, 2018-2029
6.5.7 Russia Hematology Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Hematology Drugs Market Size, 2018-2029
6.5.9 Benelux Hematology Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Hematology Drugs Revenue, 2018-2029
6.6.2 By Region – Asia Hematology Drugs Sales, 2018-2029
6.6.3 China Hematology Drugs Market Size, 2018-2029
6.6.4 Japan Hematology Drugs Market Size, 2018-2029
6.6.5 South Korea Hematology Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Hematology Drugs Market Size, 2018-2029
6.6.7 India Hematology Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Hematology Drugs Revenue, 2018-2029
6.7.2 By Country – South America Hematology Drugs Sales, 2018-2029
6.7.3 Brazil Hematology Drugs Market Size, 2018-2029
6.7.4 Argentina Hematology Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Hematology Drugs Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Hematology Drugs Sales, 2018-2029
6.8.3 Turkey Hematology Drugs Market Size, 2018-2029
6.8.4 Israel Hematology Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Hematology Drugs Market Size, 2018-2029
6.8.6 UAE Hematology Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Celgene
7.1.1 Celgene Company Summary
7.1.2 Celgene Business Overview
7.1.3 Celgene Hematology Drugs Major Product Offerings
7.1.4 Celgene Hematology Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Celgene Key News & Latest Developments
7.2 Pfizer
7.2.1 Pfizer Company Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Hematology Drugs Major Product Offerings
7.2.4 Pfizer Hematology Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Pfizer Key News & Latest Developments
7.3 Roche
7.3.1 Roche Company Summary
7.3.2 Roche Business Overview
7.3.3 Roche Hematology Drugs Major Product Offerings
7.3.4 Roche Hematology Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Roche Key News & Latest Developments
7.4 Sanof
7.4.1 Sanof Company Summary
7.4.2 Sanof Business Overview
7.4.3 Sanof Hematology Drugs Major Product Offerings
7.4.4 Sanof Hematology Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Sanof Key News & Latest Developments
7.5 Bristol-Myers Squibb
7.5.1 Bristol-Myers Squibb Company Summary
7.5.2 Bristol-Myers Squibb Business Overview
7.5.3 Bristol-Myers Squibb Hematology Drugs Major Product Offerings
7.5.4 Bristol-Myers Squibb Hematology Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Bristol-Myers Squibb Key News & Latest Developments
7.6 AbbVie
7.6.1 AbbVie Company Summary
7.6.2 AbbVie Business Overview
7.6.3 AbbVie Hematology Drugs Major Product Offerings
7.6.4 AbbVie Hematology Drugs Sales and Revenue in Global (2018-2023)
7.6.5 AbbVie Key News & Latest Developments
7.7 Novartis
7.7.1 Novartis Company Summary
7.7.2 Novartis Business Overview
7.7.3 Novartis Hematology Drugs Major Product Offerings
7.7.4 Novartis Hematology Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Novartis Key News & Latest Developments
7.8 GSK
7.8.1 GSK Company Summary
7.8.2 GSK Business Overview
7.8.3 GSK Hematology Drugs Major Product Offerings
7.8.4 GSK Hematology Drugs Sales and Revenue in Global (2018-2023)
7.8.5 GSK Key News & Latest Developments
7.9 Johnson & Johnson
7.9.1 Johnson & Johnson Company Summary
7.9.2 Johnson & Johnson Business Overview
7.9.3 Johnson & Johnson Hematology Drugs Major Product Offerings
7.9.4 Johnson & Johnson Hematology Drugs Sales and Revenue in Global (2018-2023)
7.9.5 Johnson & Johnson Key News & Latest Developments
7.10 Takeda
7.10.1 Takeda Company Summary
7.10.2 Takeda Business Overview
7.10.3 Takeda Hematology Drugs Major Product Offerings
7.10.4 Takeda Hematology Drugs Sales and Revenue in Global (2018-2023)
7.10.5 Takeda Key News & Latest Developments
8 Global Hematology Drugs Production Capacity, Analysis
8.1 Global Hematology Drugs Production Capacity, 2018-2029
8.2 Hematology Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Hematology Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Hematology Drugs Supply Chain Analysis
10.1 Hematology Drugs Industry Value Chain
10.2 Hematology Drugs Upstream Market
10.3 Hematology Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Hematology Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
世界の血液内科用治療薬市場予測2023-2029：OTC、Rx医薬品 |
| 【英語タイトル】Hematology Drugs Market, Global Outlook and Forecast 2023-2029 | |
 | ・商品コード：MMG23JU5604 ・発行会社（調査会社）：Market Monitor Global ・発行日：2023年6月 ・ページ数：76 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール（受注後2-3営業日） ・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど ・産業分野：医薬品＆医療 |
| Single User（1名様閲覧用） | USD3,250 ⇒換算￥494,000 | 見積依頼/購入/質問フォーム |
| Multi User（20名様閲覧用） | USD4,225 ⇒換算￥642,200 | 見積依頼/購入/質問フォーム |
| Enterprise User（閲覧人数制限なし） | USD4,875 ⇒換算￥741,000 | 見積依頼/購入/質問フォーム |
|
※販売価格オプションの説明 ※お支払金額：換算金額（日本円）＋消費税 ※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡） ※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能） |
| 当調査レポートは次の情報を含め、世界の血液内科用治療薬市場規模と予測を収録しています。・世界の血液内科用治療薬市場：売上、2018年-2023年、2024年-2029年 ・世界の血液内科用治療薬市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の血液内科用治療薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「OTC」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 血液内科用治療薬のグローバル主要企業は、Celgene、 Pfizer、 Roche、 Sanof、 Bristol-Myers Squibb、 AbbVie、 Novartis、 GSK、 Johnson & Johnson、 Takedaなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、血液内科用治療薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の血液内科用治療薬市場：タイプ別、2018年-2023年、2024年-2029年 世界の血液内科用治療薬市場：タイプ別市場シェア、2022年 ・OTC、Rx医薬品 世界の血液内科用治療薬市場：用途別、2018年-2023年、2024年-2029年 世界の血液内科用治療薬市場：用途別市場シェア、2022年 ・病院、ドラッグストア、その他 世界の血液内科用治療薬市場：地域・国別、2018年-2023年、2024年-2029年 世界の血液内科用治療薬市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における血液内科用治療薬のグローバル売上、2018年-2023年 ・主要企業における血液内科用治療薬のグローバル売上シェア、2022年 ・主要企業における血液内科用治療薬のグローバル販売量、2018年-2023年 ・主要企業における血液内科用治療薬のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Celgene、 Pfizer、 Roche、 Sanof、 Bristol-Myers Squibb、 AbbVie、 Novartis、 GSK、 Johnson & Johnson、 Takeda ************************************************************* ・調査・分析レポートの概要 血液内科用治療薬市場の定義 市場セグメント 世界の血液内科用治療薬市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の血液内科用治療薬市場規模 世界の血液内科用治療薬市場規模：2022年 VS 2029年 世界の血液内科用治療薬市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの血液内科用治療薬の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の血液内科用治療薬製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：OTC、Rx医薬品 血液内科用治療薬のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：病院、ドラッグストア、その他 血液内科用治療薬の用途別グローバル売上・予測 ・地域別市場分析 地域別血液内科用治療薬市場規模 2022年と2029年 地域別血液内科用治療薬売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Celgene、 Pfizer、 Roche、 Sanof、 Bristol-Myers Squibb、 AbbVie、 Novartis、 GSK、 Johnson & Johnson、 Takeda ... |
In this report, we study the drugs for Hematology. Hematology is the science or study of blood, blood-forming organs and blood diseases. In the medical field, hematology includes the treatment of blood disorders and malignancies, including types of hemophilia, leukemia, lymphoma and sickle-cell anemia.
This report aims to provide a comprehensive presentation of the global market for Hematology Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hematology Drugs. This report contains market size and forecasts of Hematology Drugs in global, including the following market information:
Global Hematology Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Hematology Drugs Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Hematology Drugs companies in 2022 (%)
The global Hematology Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
OTC Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Hematology Drugs include Celgene, Pfizer, Roche, Sanof, Bristol-Myers Squibb, AbbVie, Novartis, GSK and Johnson & Johnson, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hematology Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hematology Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Hematology Drugs Market Segment Percentages, by Type, 2022 (%)
OTC
Rx Drugs
Global Hematology Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Hematology Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital
Drugs Store
Other
Global Hematology Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Hematology Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hematology Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Hematology Drugs revenues share in global market, 2022 (%)
Key companies Hematology Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Hematology Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Celgene
Pfizer
Roche
Sanof
Bristol-Myers Squibb
AbbVie
Novartis
GSK
Johnson & Johnson
Takeda
Outline of Major Chapters:
Chapter 1: Introduces the definition of Hematology Drugs, market overview.
Chapter 2: Global Hematology Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Hematology Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hematology Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Hematology Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
❖ レポートの目次 ❖
| ★調査レポート[世界の血液内科用治療薬市場予測2023-2029：OTC、Rx医薬品] (コード：MMG23JU5604)販売に関する免責事項を必ずご確認ください。 |
| ★調査レポート[世界の血液内科用治療薬市場予測2023-2029：OTC、Rx医薬品]についてメールでお問い合わせ |
